Rechallenge of programmed cell death 1 inhibitor after an interval with dacarbazine treatment may be effective for advanced malignant melanoma.

MLA

Kan, Takanobu, et al. “Rechallenge of Programmed Cell Death 1 Inhibitor after an Interval with Dacarbazine Treatment May Be Effective for Advanced Malignant Melanoma.” The Journal of Dermatology, vol. 47, no. 8, Aug. 2020, pp. 907–10. EBSCOhost, https://doi.org/10.1111/1346-8138.15408.

APA

Kan, T., Takahagi, S., Kawai, M., Matsubara, D., Tanaka, A., & Hide, M. (2020). Rechallenge of programmed cell death 1 inhibitor after an interval with dacarbazine treatment may be effective for advanced malignant melanoma. The Journal of Dermatology, 47(8), 907–910. https://doi.org/10.1111/1346-8138.15408

Chicago

Kan, Takanobu, Shunsuke Takahagi, Mikio Kawai, Daiki Matsubara, Akio Tanaka, and Michihiro Hide. 2020. “Rechallenge of Programmed Cell Death 1 Inhibitor after an Interval with Dacarbazine Treatment May Be Effective for Advanced Malignant Melanoma.” The Journal of Dermatology 47 (8): 907–10. doi:10.1111/1346-8138.15408.